Lumida
/TYRA
⌘K
Tyra Biosciences Inc

Tyra Biosciences Inc

TYRA
$22.03USD↓-6.41%-1.51 today

MARKET CAP

1.3B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$22 – $24

52W RANGE

$12
$41

AI Summary

Stalk
Sell NowMedium

The stock is in a Stage 3 distribution with declining EMAs and failed rally attempts, indicating a bearish medium-term environment. Short-term price action shows rejection at dynamic resistance after an oversold bounce, favoring sell-side execution on any rallies into the EMA zone. The long-term trend remains down with price below a falling 200DMA, anchoring a structural bearish bias.

  • ↑SURF302 program enters pivotal trials with initial data due Sep 2026
  • ↑$353.9 M cash reserves fund R&D through H2 2028
  • ↓Earnings yield at –1.7% highlights poor revenue-to-profit conversion
Full analysis →
Sales, Adj.
No data
Gross Profit, Adj.
No data
EBITDA, Adj.
EBIT
Net Income